You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

first Complete Remission

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

Recruiting
  • Acute Myeloid Leukemia
  • Venclexta 100 MG Oral Tablet
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Jun 11, 2023

AML Trial in Moscow (allo-HSCT)

Recruiting
  • AML
  • allo-HSCT
  • Moscow, Russian Federation
    National Research Center for Hematology
Apr 14, 2022

Acute Lymphoid Leukemia, Acute Lymphoblastic Leukemia Trial in Aurora (CD19 Directed CAR T Cell)

Not yet recruiting
  • Acute Lymphoid Leukemia
  • Acute Lymphoblastic Leukemia
  • CD19 Directed CAR T Cell
  • Aurora, Colorado
    University of Colorado Hospital
Sep 12, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, Allogeneic Stem Cell Transplantation Trial in United States

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Boston, Massachusetts
  • +5 more
Oct 21, 2022

Acute Myeloid Leukemia Trial in United States (SL-401)

Terminated
  • Acute Myeloid Leukemia
  • Tampa, Florida
  • +6 more
Jan 13, 2022

Small Cell Lung Cancer Limited Stage Trial (Prophylactic cranial irradiation, Thoracic radiotherapy, Chemotherapy)

Not yet recruiting
  • Small Cell Lung Cancer Limited Stage
  • Prophylactic cranial irradiation
  • +2 more
  • (no location specified)
Dec 14, 2022

Primary CNS Lymphoma Trial in Paris (Rituximab, Methotrexate, Temozolomide)

Active, not recruiting
  • Primary Central Nervous System Lymphoma
  • Rituximab, Methotrexate, Temozolomide
  • Paris, France
    Groupe Hospitalier Pitie Salpetriere
Feb 10, 2022

Leukemia, Myeloid, Acute Trial in Germany (Human Stem Cell Transplantation, Consolidation chemo, i.e. High-dose Cytarabine

Terminated
  • Leukemia, Myeloid, Acute
  • Human Stem Cell Transplantation
  • Consolidation chemotherapy, i.e. High-dose Cytarabine (HiDAC)
  • Aachen, Germany
  • +18 more
Oct 28, 2021

Platelet Transfusion Refractoriness, Acute Leukemia in Remission Trial in Suzhou (CAR-T infusion)

Recruiting
  • Platelet Transfusion Refractoriness
  • Acute Leukemia in Remission
  • CAR-T infusion
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Oct 19, 2021

Rectal Cancer Trial in Taipei (Surgery)

Recruiting
  • Rectal Cancer
  • Surgery
  • Taipei, Taiwan
    Jin-Tung LIANG
Jul 27, 2023

Venetoclax Plasma Concentration and Remission in Acute Myeloid

Not yet recruiting
  • Adult Acute Myeloid Leukemia
  • Blood sampling for venetoclax drug dosage (venous puncture)
  • (no location specified)
Sep 13, 2023

Hodgkin Lymphoma in First Complete Remission

Completed
  • Hodgkin Lymphoma
  • +2 more
  • Standard cohort: Clinical lab follow-up
  • Imaging cohort: integrated imaging follow-up
  • (no location specified)
Mar 4, 2020

Acute Myeloid Leukemia (AML) in Remission Trial in Suzhou (Azacitidine, Venetoclax, Supportive care)

Recruiting
  • Acute Myeloid Leukemia (AML) in Remission
  • Suzhou, Jiangsu, China
  • +1 more
Aug 18, 2022

Advanced DLBCL, Extra-nodal Involvement, Large Mass, Radiotherapy Trial (6-8 cycles (21 days per cycle) of Standard R-CHOP

Not yet recruiting
  • Advanced Diffuse Large B-Cell Lymphoma
  • +2 more
  • 6-8 cycles (21 days per cycle) of Standard R-CHOP chemotherapy
  • Radiotherapy beyond standard R-CHOP Chemotherapy
  • (no location specified)
May 24, 2023

Diffuse Large B-cell Lymphoma Trial in Changchun (Mitoxantrone HCl liposome injection, RiTUXimab Injection, Cyclophosphamid)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • Mitoxantrone hydrochloride liposome injection
  • +4 more
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Aug 15, 2023

Support and Post-therapeutic Rehabilitation for Complete

Not yet recruiting
  • Non-Metastatic Breast Carcinoma
  • +2 more
    • (no location specified)
    Jul 4, 2022

    Residual Disease in Breast Cancer Remission After Primary

    Recruiting
    • Breast Cancer
    • minimally invasive preoperative image-guided vacuum-assisted biopsy
    • Milan, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    Jul 10, 2023

    Chronic GVHD Trial in Sevilla (Regulatory T-cell enriched infusion)

    Recruiting
    • Chronic Graft vs Host Disease
    • Regulatory T-cell enriched infusion
    • Sevilla, Spain
      José Antonio Pérez Simón
    May 20, 2022

    Neuroblastoma Trial (Naxitamab)

    Not yet recruiting
    • Neuroblastoma
    • (no location specified)
    Sep 18, 2023

    Medical; Abortion, Fetus Trial in Bangkok (Letrozole)

    Recruiting
    • Medical; Abortion, Fetus
    • Bangkok, Yannawa, Thailand
      Sutinee Srimahachota
    Jun 30, 2023

    Multiple Myeloma Trial in Little Rock (myPRS, Induction 1 - MEL-10+CFZ-TD-PACE, First Transplant - MEL-80+CFZ-TD-PACE + PBSC

    Terminated
    Has Results
    • Multiple Myeloma
    • myPRS
    • +6 more
    • Little Rock, Arkansas
      University of Arkansas for Medical Sciences
    May 28, 2021

    Chronic Leukemia Trial in France (Additional biological samples)

    Active, not recruiting
    • Chronic Leukemia
    • Additional biological samples
    • Besançon, France
    • +3 more
    May 31, 2022

    Hodgkin Lymphoma Trial in Belgium, Denmark, Netherlands (gemcitabine, cisplatin and tislelizumab)

    Not yet recruiting
    • Hodgkin Lymphoma
    • gemcitabine, cisplatin and tislelizumab
    • Brussels, Belgium
    • +14 more
    Aug 12, 2022

    Multiple Myeloma Trial in Baltimore (biological, drug, other)

    Recruiting
    • Multiple Myeloma
    • GM-CSF vaccine
    • +4 more
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Jan 6, 2022

    Osteosarcoma With Resectable Pulmonary Metastasis: A

    Completed
    • Osteosarcoma Metastatic
    • +3 more
    • resection group
    • radiotherapy group
    • Beijing, Beijing, China
    • +1 more
    Dec 3, 2020